Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7337411 | 0.92 | ELANE (0.62) | ELANECMA1 | |
| SCHEMBL8136651 | 0.90 | ELANE (0.63) | ELANECMA1 | |
| SCHEMBL7374559 | 0.90 | ELANE (0.63) | ELANECMA1 | |
| SCHEMBL8674112 | 0.90 | ELANE (0.63) | ELANECMA1 | |
| SCHEMBL8145232 | 0.90 | ELANE (0.63) | ELANECMA1 | |
| SCHEMBL5801511 | 0.90 | ELANE (0.63) | ELANECMA1 | |
| SCHEMBL7552455 | 0.90 | ELANE (0.63) | ELANECMA1 | |
| SCHEMBL7373453 | 0.90 | ELANE (0.63) | ELANECMA1 | |
| SCHEMBL8672185 | 0.90 | ELANE (0.63) | ELANECMA1 | |
| SCHEMBL7379996 | 0.90 | ELANE (0.63) | ELANECMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5972897-A | AN ANTIINFLAMMATORY AGENTS TREATING CYSTIC FIBROSIS AND EMPHYSEMA OR BOWEL DISEASES, A NEUTROPHIL ASSOCIATED INFLAMMATORY DISEASE, BRONCHITIS | MERRELL PHARMACEUTICALS INC. (US) | 1999-10-26 | — | — | US | disclosed |
| EP-0762887-A4 | ACYLATED ENOL DERIVATIVES AS PRODRUGS OF ELASTASE INHIBITORS | MERRELL PHARMA INC (US) | 1999-03-31 | — | — | EP | disclosed |
| EP-0762887-A1 | ACYLATED ENOL DERIVATIVES AS PRODRUGS OF ELASTASE INHIBITORS | MERRELL PHARMACEUTICALS INC. (US) | 1997-03-19 | — | — | EP | disclosed |
| WO-1995033478-A1 | ACYLATED ENOL DERIVATIVES AS PRODRUGS OF ELASTASE INHIBITORS | MERRELL PHARMACEUTICALS INC. (US) | 1995-12-14 | — | — | WO | disclosed |